Vigil Neuroscience Financials
| VIGL Stock | USD 3.05 0.01 0.33% |
Vigil |
Understanding current and past Vigil Neuroscience Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Vigil Neuroscience's financial statements are interrelated, with each one affecting the others. For example, an increase in Vigil Neuroscience's assets may result in an increase in income on the income statement.
Vigil Neuroscience Stock Summary
Vigil Neuroscience competes with Molecular Partners, Pmv Pharmaceuticals, Monte Rosa, Entrada Therapeutics, and Third Harmonic. Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Vigil Neuroscience, Inc. operates as a subsidiary of Amgen Inc. Vigil Neuroscience operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 48 people.Specialization | Healthcare, Biotechnology |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US92673K1088 |
| CUSIP | 92673K108 |
| Location | Massachusetts; U.S.A |
| Business Address | 100 Forge Road, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.vigilneuro.com |
| Phone | 857 254 4445 |
| Currency | USD - US Dollar |
Vigil Neuroscience Key Financial Ratios
Vigil Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Vigil Neuroscience's current stock value. Our valuation model uses many indicators to compare Vigil Neuroscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vigil Neuroscience competition to find correlations between indicators driving Vigil Neuroscience's intrinsic value. More Info.Vigil Neuroscience is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Vigil Neuroscience by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Vigil Neuroscience Systematic Risk
Vigil Neuroscience's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Vigil Neuroscience volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Vigil Neuroscience correlated with the market. If Beta is less than 0 Vigil Neuroscience generally moves in the opposite direction as compared to the market. If Vigil Neuroscience Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Vigil Neuroscience is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Vigil Neuroscience is generally in the same direction as the market. If Beta > 1 Vigil Neuroscience moves generally in the same direction as, but more than the movement of the benchmark.
Vigil Neuroscience November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Vigil Neuroscience help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Vigil Neuroscience. We use our internally-developed statistical techniques to arrive at the intrinsic value of Vigil Neuroscience based on widely used predictive technical indicators. In general, we focus on analyzing Vigil Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Vigil Neuroscience's daily price indicators and compare them against related drivers.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 19.63 | |||
| Value At Risk | (6.30) | |||
| Potential Upside | 5.29 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vigil Neuroscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more information on how to buy Vigil Stock please use our How to buy in Vigil Stock guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vigil Neuroscience. If investors know Vigil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vigil Neuroscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Vigil Neuroscience is measured differently than its book value, which is the value of Vigil that is recorded on the company's balance sheet. Investors also form their own opinion of Vigil Neuroscience's value that differs from its market value or its book value, called intrinsic value, which is Vigil Neuroscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vigil Neuroscience's market value can be influenced by many factors that don't directly affect Vigil Neuroscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vigil Neuroscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vigil Neuroscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vigil Neuroscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.